Taro Pharmaceutical Industries (TARO) Company Profile & Statistics

Taro Pharmaceutical Industries
TARO
(NYSE)
N/A
42.49
-0.02 (-0.05%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
42.43
High
42.59
Low
42.43

About Taro Pharmaceutical Industries

CEO

Uday Baldota

Headquarters

14 hakitor street

haifa bay, l3 2624761, israel

Auditor

Ziv Haft

Employees

1,554

Share Holders

N/A

Website

www.taro.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.

Taro Pharmaceutical Industries Statistics

Valuation Measures

Market Capitalization ²	1.60B
Enterprise Value	1.16B
Enterprise Value/EBITDA (ttm)	23.04
Price to Earnings Ratio (ttm)	27.93
Price to Book (mrq)	0.90
Price to Sales (ttm)	2.61
Price to Cash (ytd)	24.27

Profitability

Gross Margin (ttm)	48.12%
Operating Margin (ttm)	9.34%
Profit Margin (ttm)	7.41%
Return on Equity (ttm)	3.26%
Return on Invested Capital (ttm)	2.60%
Return on Assets (ttm)	2.67%

Income Statement

Revenue (ttm)	610.83M
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	293.27M
EBITDA (ttm)³	50.28M
Net Income Avi to Common (ttm)	45.70M
Diluted EPS (ttm)	1.22

Share Statistics

Beta (5Y Monthly)	0.60
52-Week Change	46.77%
S&P500 52-Week Change	27.21%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	32.40M
% Held by Insiders	13.80%
% Held by Institutions	91.40%

Balance Sheet

Total Cash (mrq)	902.22M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.60%
Quick Ratio (mrq)	3.03%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	2.29
Free Cash Flow (ytd)	37.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Taro Pharmaceutical Industries

Trade With A Regulated Broker